BofA Downgrades Zoetis (ZTS) to Neutral, Cuts Price Target [Yahoo! Finance]
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: Yahoo! Finance
On December 15, BofA downgraded Zoetis Inc. (NYSE:ZTS) to Neutral from Buy and lowered its price target to $135 from $165. In other news, on December 5, Zoetis Inc. (NYSE:ZTS) announced that Health Canada approved Portela™ (relfovetmab injection) for the relief of pain linked to osteoarthritis, or OA, in cats. Portela is designed to deliver up to three months of OA pain relief with a single injection. The treatment targets anti-nerve growth factor (NGF), a key driver of OA pain and inflammation. In a nine-month field trial conducted in Europe, Portela showed it could effectively reduce OA pain and was generally well tolerated. That included cats diagnosed with kidney disease at IRIS stage 1, 2, or 3. Portela is already approved in the European Union, and Zoetis expects to make it commercially available in Canada and the EU in 2026. Rob Polzer, Ph.D., Executive Vice President and President, Research and Development at Zoetis, made the following comment: “Health Canada's approv
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- Zoetis (ZTS): Harnessing Growth with Minimum Rivalry [Yahoo! Finance]Yahoo! Finance
- ???????????????????? : ????????????????????????????·?????????????2033??61?3000???????????? [CNET News]CNET News
- Zoetis (NYSE:ZTS) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
- Zoetis (NYSE:ZTS) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat
ZTS
Earnings
- 11/4/25 - Beat
ZTS
Sec Filings
- 1/9/26 - Form 3
- 1/7/26 - Form SCHEDULE
- 12/18/25 - Form 8-K
- ZTS's page on the SEC website